Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19
Clinical trial NCT05908071 · UNKNOWN
Trial details
- NCT number
- NCT05908071
- Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-13
- Primary completion
- 2024-05-01
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.